Investors Buy Shares of Metlife (MET) on Weakness

Investors purchased shares of Metlife Inc (NYSE:MET) on weakness during trading hours on Monday. $70.95 million flowed into the stock on the tick-up and $24.81 million flowed out of the stock on the tick-down, for a money net flow of $46.14 million into the stock. Of all equities tracked, Metlife had the 17th highest net in-flow for the day. Metlife traded down ($0.61) for the day and closed at $45.25

MET has been the topic of several analyst reports. Sandler O’Neill upgraded shares of Metlife from a “hold” rating to a “buy” rating in a research note on Wednesday, January 2nd. Wells Fargo & Co reiterated a “buy” rating on shares of Metlife in a research note on Tuesday, January 8th. Bank of America upgraded shares of Metlife from a “neutral” rating to a “buy” rating and set a $44.06 price objective on the stock in a research report on Wednesday, January 16th. ValuEngine upgraded shares of Metlife from a “sell” rating to a “hold” rating in a research report on Wednesday, January 16th. Finally, Zacks Investment Research downgraded shares of Metlife from a “buy” rating to a “hold” rating in a research report on Monday, January 21st. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $52.76.

The firm has a market cap of $44.22 billion, a P/E ratio of 8.47, a P/E/G ratio of 0.98 and a beta of 1.18. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.26.

Metlife (NYSE:MET) last announced its earnings results on Wednesday, February 6th. The financial services provider reported $1.35 EPS for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.05. Metlife had a net margin of 7.53% and a return on equity of 10.24%. The business had revenue of $15.40 billion during the quarter, compared to analysts’ expectations of $15.84 billion. During the same period in the prior year, the company earned $0.64 earnings per share. The firm’s revenue was up .0% on a year-over-year basis. Analysts predict that Metlife Inc will post 5.48 EPS for the current fiscal year.

In other Metlife news, EVP Steven J. Goulart sold 10,292 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $44.40, for a total transaction of $456,964.80. Following the completion of the sale, the executive vice president now directly owns 93,214 shares of the company’s stock, valued at $4,138,701.60. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO John D. Mccallion sold 2,669 shares of the company’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $44.43, for a total transaction of $118,583.67. Following the sale, the chief financial officer now directly owns 20,538 shares of the company’s stock, valued at $912,503.34. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. JNBA Financial Advisors purchased a new stake in shares of Metlife in the fourth quarter worth $26,000. Bruderman Asset Management LLC purchased a new stake in shares of Metlife in the fourth quarter worth $27,000. Berman Capital Advisors LLC purchased a new stake in shares of Metlife in the fourth quarter worth $31,000. Executive Wealth Management LLC purchased a new stake in shares of Metlife in the fourth quarter worth $34,000. Finally, Country Trust Bank increased its stake in shares of Metlife by 1,052.6% in the fourth quarter. Country Trust Bank now owns 876 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 800 shares in the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Stock Observer and is the property of of Stock Observer. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.thestockobserver.com/2019/04/17/investors-buy-shares-of-metlife-met-on-weakness.html.

About Metlife (NYSE:MET)

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Further Reading: What Is An Exchange-Traded Fund (ETF)?

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.